Comparison

QS/1 eSigcap vs mConsent Eaglesoft

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

QS/1 eSigcap

This application allows pharmacies to capture electronic signatures for prescription systems and process cash or check payments. It supports delivery workflows and includes an offline mode for capturing signatures without an internet connection, uploading them later.

Highlights
  • Electronic signature capture
  • Check and cash payment processing
  • Delivery workflow support
  • Offline mode for signature capture
  • Integration with QS/1 NRx and POS
Features
Read full description

QS/1's electronic signature capture app for Ipad. eSigcap allows your Pharmacy to capture signatures for QS/1's NRx and POS system. It can also be used to process check and cash payments in the POS system. eSigcap also has support for deliveries and a offline mode so you can capture signatures when a internet connection is not available and upload them later to the QS/1 system.

About

mConsent Eaglesoft

Streamline the process of submitting consent forms directly from an iPad to the Eaglesoft dental practice management system. This application simplifies patient intake and record-keeping for dental professionals.

Highlights
  • Submit consent forms
  • Directly from iPad
  • Integrates with Eaglesoft
  • Simplifies patient intake
  • Digital record-keeping
Features
Read full description

Submit consent forms directly from iPad to Eaglesoft

Verdict

The call

The clearest difference is rating: mConsent Eaglesoft at 4.0 against QS/1 eSigcap's 1.0. mConsent Eaglesoft also leads on ratings volume (4 vs 1). QS/1 eSigcap's advantage is iOS requirement (8.0 vs 12.0). On price, update cadence, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

mConsent Eaglesoft holds the better App Store score, 4.0 against 1.0. Both are backed by a comparable volume of ratings — 1 and 4 respectively.

UpkeepUpdate frequency

QS/1 eSigcap ships an update every 4 months, mConsent Eaglesoft every 3 months. The most recent releases landed on June 25, 2026 and August 15, 2026 respectively.

Scorecard3 real differences · 6 level
QS/1 eSigcap versus mConsent Eaglesoft: the parameters behind the verdict, then further details
ParameterQS/1 eSigcapmConsent Eaglesoft
PriceFreeFree
Rating1.0 (1 ratings)4.0 (4 ratings) — better
Number of ratings14 — better
Update frequencyEvery 4 monthsEvery 3 months — better
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPadiPad
Requires iOS8.0 — better12.0
Further details — not scored
Size69 MB61 MB
Age rating4+4+
DeveloperRedSail Technologies, LLCSRS web solutions inc

Customer experience

QS/1 eSigcap

All ratings1 ratings
Positive0.0%
Neutral0.0%
Negative100.0%

mConsent Eaglesoft

All ratings4 ratings
Positive75.0%
Neutral0.0%
Negative25.0%

In-app purchases

None

QS/1 eSigcap

No in-app purchases

None

mConsent Eaglesoft

No in-app purchases

Questions

Is QS/1 eSigcap free?
QS/1 eSigcap is free to download, with no in-app purchases.
Is mConsent Eaglesoft free?
mConsent Eaglesoft is free to download, with no in-app purchases.
Which has better reviews, QS/1 eSigcap or mConsent Eaglesoft?
mConsent Eaglesoft is rated higher. QS/1 eSigcap averages 1.0 out of 5 from 1 ratings, while mConsent Eaglesoft averages 4.0 from 4 ratings.
Do QS/1 eSigcap or mConsent Eaglesoft have ads?
Neither QS/1 eSigcap nor mConsent Eaglesoft shows ads.
Which is updated more often, QS/1 eSigcap or mConsent Eaglesoft?
QS/1 eSigcap ships an update every 4 months, and mConsent Eaglesoft every 3 months. Most recently, QS/1 eSigcap was updated on June 25, 2026 and mConsent Eaglesoft on August 15, 2026.

Other comparisons